This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arexis Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Marcel Linschoten: Innovator in Skin Disease Treatment
Introduction
Marcel Linschoten is a notable inventor based in Haninge, Sweden. He has made significant contributions to the field of medical science, particularly in the treatment of skin diseases and cancer. His innovative approach focuses on the use of heterocyclic compounds as inhibitors for specific enzymes.
Latest Patents
Linschoten holds a patent for the "Use of heterocyclic compounds as SCCE inhibitors." This invention relates to heterocyclic inhibitors of stratum corneum chymotryptic enzyme (SCCE). More specifically, it addresses the use of compounds with the formula (I) or (II) for treating various diseases, including skin conditions such as pruritus and cancers like ovarian cancer. He has 1 patent to his name.
Career Highlights
Marcel Linschoten is associated with Arexis AB, a company that focuses on developing innovative therapies. His work at Arexis AB has allowed him to explore and advance his research in the medical field. His dedication to improving treatment options for patients is evident in his patent work.
Conclusion
Marcel Linschoten is a pioneering inventor whose work has the potential to impact the treatment of skin diseases and cancer significantly. His innovative use of heterocyclic compounds showcases the importance of research and development in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile